Location out of bounds
Inflammasome Image

2019 Immunology Symposium

This annual event brings together prominent researchers presenting current research in the field of immunology.

Event Contact

Jenny Wojtysiak

Research Administration, Blood Research Institute
Email 414-937-3854

Pathogen Recognition in Innate Immunity

Registration is free - Click here to register

13th Annual Immunology Symposium

Date: October 30th, 2019

Blood Research Institute
8733 W. Watertown Plank Rd.
Milwaukee, WI 53226

The Annual Immunology Symposium covers the latest on Pathogen Recognition in Innate Immunity.

13th Annual Immunology Symposium Agenda

Featured Speakers:


Center for Immunology, Medical College of Wisconsin Graduate Student Invited Speaker:

Marco Colonna, MD

Marco Colonna, MD

Washington University School of Medicine in St. Louis

Presentation
Innate Lymphoid Cells in Mucosal Immunity


Sun Hur, PhD

Sun Hur, PhD

Harvard Medical School

Presentation
RIG-I-like Receptors and Inflammation


Egil Lien, PhD

Egil Lien, PhD

University of Massachusetts Medical School

Presentation
Pathogen Manipulation of Innate Immunity – Implications on Signaling and Cell Death


Jyotika Sharma, PhD

Jyotika Sharma, PhD

University of North Dakota

Presentation
Neutrophil Extracellular Traps: Formation and Therapeutic Implications


Jenifer Coburn, PhD

Jenifer Coburn, PhD

Medical College of Wisconsin

Presentation
Spirochetes Stealthily Sneak Around Innate Immunity


Suzanne Cassel, MD

Suzanne Cassel, MD

Cedars-Sinai Medical Center

Presentation
NLRC4 Regulation of the Anti-Influenza Immune Response

Organizing Committee Chairs: 

Weiguo Cui, MD, PhD WCui@versiti.org
Bonnie Dittel, PhD BDittel@Versiti.org
Jack Gorski, PhD JGorski@versiti.org

Speakers and Materials From Previous Events

  • 12th Annual Immunology Symposium: B Cells and Broadly Neutralizing Antibodies

    Featured Speakers and Topics

    Frederick W. Alt, PhD: New Insights into Mechanisms that Generate Primary and Peripheral B Cell Repertoires

    Investigator, Howard Hughes Medical Institute; Director, Program in Cellular and Molecular Medicine, Boston Children’s Hospital; Charles A. Janeway Professor of Pediatrics and Professor of Genetics, Harvard Medical School

    James E. Crowe, MD: Molecular and Genetic Basis for Development of Broad and Potent Neutralizing Antibodies

    Ann Scott Carell Chair; Professor of Pediatrics, Pathology, Microbiology, and Immunology; Director, Vanderbuilt Vaccine Center, Vanerbuilt University School of Medicine

    Gary J. Nabel, MD, PhD: Development of Trispecific Antibodies for AIDS and Cancer

    Chief Scientific Officer, Senior Vice President, Sanofi

    William Schief, PhD: Germline-Targeting Vaccine Design for HIV

    Professor of Immunology and Microbial Science, The Scripps Research Institute

    Betty Diamond, MD: Origins of Autoreactive B cells in Systemic Lupus

    Head, The Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research

    Demin Wang, PhD: B Cell and Antibody Response in Heparin-induced Thrombocytopenia

    John B. and Judith A. Gardetto Chair for Cancer Research, Senior Investigator, Blood Research Institute, Versiti Blood Center of Wisconsin
     


    Event Materals

  • 11th Annual Immunology Syposium: Immunology in Precision Medicine

    Featured Speakers and Topics

    Mark M. Davis, PhD: New Tools for T cells: A Window on Many Human Diseases

    Investigator, Howard Hughes Medical Institute; Professor, Department of Microbiology and Immunology; Director, Stanford Institute for Immunity, Transplantation, and Infection; Member of the National Academy of Sciences (NAS); Stanford University School of Medicine

    Ming Li, PhD: Tolerance and Immunity in Health and Cancer

    Professor, Gerstner Sloan Kettering Graduate School; Professor, Weill Cornell Graduate School of Medical Sciences; Principal Investigator/Member, Immunology Program; Faculty Scholar, Howard Hughes Medical Institute/Memorial Sloan Kettering Cancer Center

    Edward M. Behrens, MD: Toward Developing a Precision Approach to the Cytokine Storm

    Joseph Lee Hollander Associate Professor in Pediatric Rheumatology, Perelman School of Medicine at the University of Pennsylvania; Division Chief of Rheumatology, Children’s Hospital of Philadelphia

    Yi-Guang Chen, PhD: Genetic Control of Type 1 Diabetes: Learning From the NOD Mouse

    Associate Professor of Pediatrics (Endocrinology), Microbiology and Immunology; Medical College of Wisconsin

    Gail Bishop, PhD: TRAF3 & B Cells: Understanding Biology to Inform Treatment of B Cell Malignancies

    Professor of Microbiology and Internal Medicine; Director, Center for Immunology and Immune-Based Diseases; Associate Director for Basic Science Research, Holden Comprehensive Cancer Center; Holden Chair of Cancer Biology, The University of Iowa

    Arup Chakraborty, PhD: How to Hit HIV Where it Hurts

    Director of Institute for Medical Engineering and Science (IMES), Robert T. Haslam Professor of Chemical Engineering; Professor of Physics, Chemistry, and Biological Engineering; Member of the National Academy of Sciences (NAS); Massachusetts Institute of Technology (MIT)
     


    Event Materials


Immunology Then and Now


Immunology in the form of immunohematology was a key component of the activity of the early “Milwaukee Blood Center,” which eventually became Versiti. The discovery of the role of human leukocyte antigens (HLA) on platelets in transfusion led to HLA typing to match platelet donors. This led to Versiti Blood Center being selected as the national depository for rare bone marrow donor types, which evolved into the National Marrow Donor program. In 1979, Versiti Blood Center investigators discovered a new HLA histocompatibility system, now known as HLA-DQ. With its expertise in HLA, Versiti Blood Center was able to facilitate the first unrelated bone marrow transplant in 1981. It was an early adopter of T- cell typing and was one of the first institutions in the U.S. to implement molecular genetic-based HLA typing. Today’s Versiti continues to provide expanded HLA typing using high-throughput DNA sequencing.

Immunologists at the BRI currently conduct cutting-edge research in cancer, infectious disease and autoimmunity. Investigators are developing new methods for eradicating cancer by using novel immunotherapies. In infectious disease, the work by BRI immunologists studying how the immune system recognizes and responds to viruses is opening new avenues for the treatment and prevention of viral infections. Studies in autoimmunity include how B and T lymphocytes contribute to and regulate autoimmunity.

The immunology community at BRI/MCW is well organized and in addition to the yearly Immunology Symposium, now in its 13th year, offers a variety of training opportunities. These include both pre-doctoral graduate courses and advanced training in clinical immunology. The immunology faculty also facilitate a weekly journal club, a weekly work-in-progress and a yearly internal conference/retreat.

The strength of and leading role of Immunology on the Medical College campus has led to the founding of the Center for Immunology, which is dedicated to helping translate our understanding of basic research to problems faced by Medical College physicians.

ic-arrow-right
x

This website uses cookies to ensure you get the best experience on our website. Learn more